At NSE, shares of the company slipped by 7.27 percent to hit a one-year low of Rs 744.95. The stock was the biggest loser on Sensex and Nifty indices.
    
Drug major Sun Pharma on Saturday reported a 46.02 percent dip in consolidated net profit to Rs 1,106.66 crore for the quarter ended September 30, due to lower sales growth, volatile currency movements and supply constraints.
    
The company had posted a net profit of Rs 2,050.22 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries had said in a statement.
    
Consolidated net sales of the company declined to Rs 6,803.31 crore for the quarter under consideration as against Rs 7,979.31 crore for the same period a year ago.
    
Sun Pharma Managing Director Dilip Shanghvi had said, "Our performance for the quarter and first half FY16 has been impacted by lower sales growth, volatile currency movements and supply constraints."

 

Latest News  from Business News Desk